Literature DB >> 29895189

Interaction of p53 and ASPPs regulates rhesus monkey embryonic stem cells conversion to neural fate concomitant with apoptosis.

Shuang Wang1,2, Lichuan Yang3,4, Raoxian Bai1,2, Shuaiwei Ren1,2, Yuyu Niu1,2, Yuanye Ma4, Weizhi Ji1,2, Yongchang Chen1,2,4.   

Abstract

The tumor suppressor p53 is a key regulator of cell apoptosis and cell cycle arrest. Recent studies show that the delicate balance of p53 expression is important for neural tube defects, neuronal degeneration, embryonic lethality, as well as differentiation and dedifferentiation. Moreover, p53 showed different regulatory patterns between rodent and primate embryonic stem cells (ESCs). However, the role of p53 and apoptosis stimulating protein of p53 (ASPP) during neural differentiation (ND) from primate ESCs is still unknown. In this study, using an FGF-2 and/or HGF selectively containing ND culture systems for rhesus monkey ESCs (rESCs), the changes of p53 and ASPPs, and p53 targets, i.e. BAX and p21, were analyzed. Our results showed that the expression patterns of ASPP1/ASPP2 and iASPP were opposite in rESCs but similar in differentiated cells, and the expression of p53 was approximately consistent with BAX, but not p21. These findings indicate that the strong expression of iASPP in ESCs and weak expression of ASPP1/ASPP2 maintain the stability of stemness; and in ND niche, unimpaired iASPP may decrease its inhibition of ASPP1/ASPP2 expression, the interaction of p53 and ASPPs causing rESCs to convert towards a neural fate concomitant with apoptosis, but not to cell cycle arrest.

Entities:  

Keywords:  ASPP; ND; P53; apoptosis; cell cycle arrest; rESCs

Year:  2018        PMID: 29895189      PMCID: PMC6110590          DOI: 10.1080/15384101.2018.1464848

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  29 in total

Review 1.  Neural differentiation from embryonic stem cells: which way?

Authors:  Zhong-Wei Du; Su-Chun Zhang
Journal:  Stem Cells Dev       Date:  2004-08       Impact factor: 3.272

2.  Feeder-independent culture of human embryonic stem cells.

Authors:  Tenneille E Ludwig; Veit Bergendahl; Mark E Levenstein; Junying Yu; Mitchell D Probasco; James A Thomson
Journal:  Nat Methods       Date:  2006-08       Impact factor: 28.547

3.  Basic fibroblast growth factor support of human embryonic stem cell self-renewal.

Authors:  Mark E Levenstein; Tenneille E Ludwig; Ren-He Xu; Rachel A Llanas; Kaitlyn VanDenHeuvel-Kramer; Daisy Manning; James A Thomson
Journal:  Stem Cells       Date:  2005-11-10       Impact factor: 6.277

Review 4.  ASPP2: a gene that controls life and death in vivo.

Authors:  Virginie Vives; Elizabeth A Slee; Xin Lu
Journal:  Cell Cycle       Date:  2006-10-01       Impact factor: 4.534

5.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

6.  Neural progenitors derived from monkey embryonic stem cells in a simple monoculture system.

Authors:  Xinjie Chen; Tianqing Li; Xuemei Li; Yunhua Xie; Xiangyu Guo; Shaohui Ji; Yiyu Niu; Yang Yu; Chenhui Ding; Ruqiang Yao; Shihua Yang; Weizhi Ji; Qi Zhou
Journal:  Reprod Biomed Online       Date:  2009-09       Impact factor: 3.828

Review 7.  The p53 response to DNA damage.

Authors:  David W Meek
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

8.  ASPP1 and ASPP2: common activators of p53 family members.

Authors:  Daniele Bergamaschi; Yardena Samuels; Boquan Jin; Sai Duraisingham; Tim Crook; Xin Lu
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 9.  Human ESC-derived neural rosettes and neural stem cell progression.

Authors:  Y Elkabetz; L Studer
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-02-09

10.  Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage.

Authors:  Valeriya Solozobova; Alexandra Rolletschek; Christine Blattner
Journal:  BMC Cell Biol       Date:  2009-06-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.